Targeting the intratumor heterogeneity in PMBL.
Ritz, Olga
Targeting the intratumor heterogeneity in PMBL. [electronic resource] - Cell cycle (Georgetown, Tex.) 2014 - 2317-8 p. digital
Publication Type: Editorial
1551-4005
10.4161/cc.29828 doi
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cyclophosphamide--therapeutic use
Doxorubicin--therapeutic use
Female
Genetic Heterogeneity
Humans
Lymphoma, B-Cell--genetics
Mediastinal Neoplasms--genetics
Oncogenes
Prednisone--therapeutic use
Rituximab
Secondary Prevention
Vincristine--therapeutic use
Targeting the intratumor heterogeneity in PMBL. [electronic resource] - Cell cycle (Georgetown, Tex.) 2014 - 2317-8 p. digital
Publication Type: Editorial
1551-4005
10.4161/cc.29828 doi
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cyclophosphamide--therapeutic use
Doxorubicin--therapeutic use
Female
Genetic Heterogeneity
Humans
Lymphoma, B-Cell--genetics
Mediastinal Neoplasms--genetics
Oncogenes
Prednisone--therapeutic use
Rituximab
Secondary Prevention
Vincristine--therapeutic use